🌱 KidneyEnergy.com

← brief for 2026-08-15 · Slowing decline

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Article B Peer reviewed Small trial

Key takeaways

Pharmacist-led prescribing of ACE inhibitors or ARBs and SGLT2 inhibitors was validated for patients with eGFR >=30. This protocol could help bridge gaps in guideline-directed therapies.

Who did this work

Sheffield M · Phelan E · Ratajczak N · Battistella M · Tennankore K · Odutayo A · Soroka S · Poyah P · More K · Naylor H · Kennie-Kaulbach N · Rainkie D

Source

Article · PubMed, the drug frontier · 2026 Aug 13
https://pubmed.ncbi.nlm.nih.gov/42602345/